US Patent Issued to Synthekine on April 29 for "IL10RB binding molecules and encoding nucleic acids" (California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,482, issued on April 29, was assigned to Synthekine Inc. (Menlo Park, Calif.).

"IL10RB binding molecules and encoding nucleic acids" was invented by Robert Kastelein (Menlo Park, Calif.), Sandro Vivona (Menlo Park, Calif.), Deepti Rokkam (Menlo Park, Calif.) and Patrick J. Lupardus (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to biologically active molecules comprising a single domain antibody (sdAb) that specifically binds to the extracellular domain of human IL10Rb, compositions comprising such antibodies, and methods of use thereof."

The patent was filed on Aug. 5, 2021, under Application No. 1...